Expanded Access Program for Revumenib
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Children's Hospital of Philadelphia
UNC Lineberger Comprehensive Cancer Center
University of California, San Francisco
AstraZeneca
Novartis
Barbara Ann Karmanos Cancer Institute
BTG International Inc.